We speculate that the inconsistent results obtained by different studies regarding the effect of BCL2 on prognoses for DLBCL, may be partly attributable to the complexity of BCL2 genetic alterations. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.